We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AVENTIS TO FILE REPORT WITH FDA OVER DRUG DEATHS IN JAPAN
AVENTIS TO FILE REPORT WITH FDA OVER DRUG DEATHS IN JAPAN
January 30, 2004
Faced with a barrage of international news stories, Aventis said last week it would file a report with the FDA about the deaths of five Japanese patients participating in a postmarketing study of its rheumatoid arthritis drug Arava, although the company contends there is no clear evidence the drug caused the fatalities.